- Last Close 0.06
- Sector Healthcare
- Industry Biotechnology
- Investment Style
- Day Range 0.06 – 0.07
- Year Range 0.02 – 0.10
- Market Cap 7.8869 Mil
- Volume / Avg 98,902.0 / 35,072.7
- Price / Sales —
- Price / Book 2,190.81
- Forward Div Yield 5.13%
- Trailing Div Yield —
Morningstar‘s Stock Analysis BZYR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile BZYR
Burzynski Research Institute Inc engages in the research, production, marketing, promotion, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are used in the treatment of human cancer. Its pipeline development programs of the company include clinical trials for the treatment of a wide variety of cancers using only a combination of Antineoplastons A10 and AS2-1.
Houston, TX, 77055
FAQs for Burzynski Research Institute Inc Stock
Yes. BZYR has a forward dividend yield of 5.13%.
BZYR’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
BZYR’s market cap is 7.89 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
BZYR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare BZYR’s historical performance against its industry peers and the overall market.